NO950602L - Antiangiogeniske oligomerer - Google Patents

Antiangiogeniske oligomerer

Info

Publication number
NO950602L
NO950602L NO950602A NO950602A NO950602L NO 950602 L NO950602 L NO 950602L NO 950602 A NO950602 A NO 950602A NO 950602 A NO950602 A NO 950602A NO 950602 L NO950602 L NO 950602L
Authority
NO
Norway
Prior art keywords
oligomers
antiangiogenic
polyureas
metastases
polycarbonates
Prior art date
Application number
NO950602A
Other languages
English (en)
Other versions
NO950602D0 (no
Inventor
Paul Steven Wright
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO950602D0 publication Critical patent/NO950602D0/no
Publication of NO950602L publication Critical patent/NO950602L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Oligomerene ifølge oppfinnelsen er polyureaer, polykarbonater, poly- estere eller polyamider med en antalls- midlere molekylvekt på < 10 000. Disse oligomerer er vannløselige, har en stiv ryggrad med en forutsigbar anionavstand og er farmasøytisk akseptable. Oligo- merene er anvendbare for inhibering av angiogenese og kan anvendes ved behand- ling av tumorer og metastaser.
NO950602A 1992-08-19 1995-02-17 Antiangiogeniske oligomerer NO950602L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93211192A 1992-08-19 1992-08-19
PCT/US1993/006792 WO1994004165A1 (en) 1992-08-19 1993-07-20 Antiangiogenic oligomers

Publications (2)

Publication Number Publication Date
NO950602D0 NO950602D0 (no) 1995-02-17
NO950602L true NO950602L (no) 1995-02-17

Family

ID=25461789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950602A NO950602L (no) 1992-08-19 1995-02-17 Antiangiogeniske oligomerer

Country Status (12)

Country Link
US (1) US5593664A (no)
EP (1) EP0655923A1 (no)
JP (1) JPH08500590A (no)
AU (1) AU675961B2 (no)
CA (1) CA2142110A1 (no)
HU (1) HUT72993A (no)
IL (1) IL106707A (no)
MX (1) MX9305010A (no)
NO (1) NO950602L (no)
NZ (1) NZ254646A (no)
WO (1) WO1994004165A1 (no)
ZA (1) ZA935941B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0749690A1 (en) 1995-06-22 1996-12-27 Unilever N.V. Heat-settable, frozen bakery dough systems
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US20040022788A1 (en) 1998-05-19 2004-02-05 Moser Tammy L. Compositions and methods for promoting or inhibiting angiogenesis
ATE276763T1 (de) 1998-07-13 2004-10-15 Univ Texas Verwendung von antikörper gegen aminophospholipide zur krebsbehandlung
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
GB0001481D0 (en) * 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
EP2357009A1 (en) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
US20050203063A1 (en) * 2003-09-12 2005-09-15 Raymond Deshaies Proteasome pathway inhibitors and related methods
ES2809302T3 (es) 2004-01-22 2021-03-03 Univ Miami Formulaciones de coenzima Q10 para tratar tumores sólidos mediante administración intravenosa
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
EP2633864A1 (en) 2008-07-25 2013-09-04 The Regents of the University of Colorado Clip inhibitors and methods of modulating immune function
CN102382300B (zh) * 2011-10-11 2013-05-08 上海交通大学 一种水溶性磺化聚酰胺及其制备方法
EP3576726A1 (en) 2017-02-06 2019-12-11 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
JPH0140026B2 (no) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US5019556A (en) * 1987-04-14 1991-05-28 President And Fellows Of Harvard College Inhibitors of angiogenin
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process

Also Published As

Publication number Publication date
JPH08500590A (ja) 1996-01-23
HU9500493D0 (en) 1995-04-28
HUT72993A (en) 1996-06-28
IL106707A0 (en) 1993-12-08
WO1994004165A1 (en) 1994-03-03
MX9305010A (es) 1994-03-31
NZ254646A (en) 1997-06-24
ZA935941B (en) 1994-03-10
NO950602D0 (no) 1995-02-17
AU4684893A (en) 1994-03-15
IL106707A (en) 1997-02-18
AU675961B2 (en) 1997-02-27
EP0655923A1 (en) 1995-06-07
CA2142110A1 (en) 1994-03-03
US5593664A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
NO950602L (no) Antiangiogeniske oligomerer
NO930052L (no) Anti-herpesvirus og cytomegalovirusoligomerer
ATE148346T1 (de) Antiproliferative oligomere
GR3029861T3 (en) Heparin derivatives having antimetastatic activity
WO1997045137A8 (en) Methods and compositions useful for inhibition of angiogenesis
EP1298211A3 (en) Polynucleotide segment of HPV16 Genome
DK0526528T3 (da) Vanddispergerbare polyestere, der meddeler forbedrede vandbestandighedsegenskaber til tryksværter
DE3650215D1 (de) Orientiertes, silanvernetztes Polyäthylen-Produkt von ultrahohem Molekulargewicht und Verfahren zu dessen Herstellung.
NO912794D0 (no) Boresystem og fremgangsmaate for styring av retningen paa boringer i grunnformasjoner.
EP0682665A4 (en) ANTHRAQUINONE AND ANTHRACENE DERIVATIVES INHIBITING CELL ADHESION MOLECULES OF THE IMMUNE SYSTEM.
Osipenko et al. Recovery problems in Hardy and Bergman spaces
Caletti et al. Role of endoscopic ultrasonography in the treatment of esophageal varices
NO943498D0 (no) Fremgangsmåte til fremstilling av höymolekylære polyestre
EP0610931A3 (en) Production method of strong and tough thick steel plate.
CA2079663A1 (en) Dithiocarbamate polymers
MY103724A (en) Organo-phosphorous energy transfer agents
Saelee Determinants of private investment in Thailand
CA2179988A1 (en) Pharmaceutical formulations comprising polythiourea and method of use thereof
HU913322D0 (en) Product for the prevention of polymer-accumulation, and polymerizing apparatus
WO2000029433A3 (en) 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
韩孝族 et al. SYNTHESIS AND CHARACTERIZATION OF BLOCK POLYMER OF ALTERNATING COPOLYMERS
Pasloske Molecular studies of the NMePhe Pilin of Pseudomonas aeruginosa
El-Hakim Effect of surface treatment on the corrosion protective properties of Egyptian manganese ore primers, pt. 2
Casta et al. Progress in the Understanding and Prevention of Corrosion. Vol. II
Boumah Studies on the human myelin basic protein gene